MIVI Neuroscience Presents Primary Endpoint Results from the EvaQ Trial — at the 2024 International Stroke Conference
Primary effectiveness endpoint results show high revascularization rates of 93.9% mTICI 2b/3
Stay updated with breaking news from Guide Catheter. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Primary effectiveness endpoint results show high revascularization rates of 93.9% mTICI 2b/3
Medtronic, a medical device company, has secured 510(k) clearance from the FDA for 16 new devices since the beginning of 2023, including several spinal and orth
Growing patient knowledge about the accessibility of treatment and devices, and realigning reimbursement systems, are expected to boost market demand, particularly in emerging markets. Furthermore, the emergence of new catheters with superior ergonomics and enhanced clinical efficiency is propelling the global usage of these instruments in neurovascular procedures.Wilmington, Delaware, United States, June 16, 2023 (GLOBE NEWSWIRE) -- In 2021, the worldwide neurovascular catheter market was estim
Medtronic, Inc. et al. v. Teleflex Innovations S.A.R.L., Appeal Nos. 2021-2356, -2358, -2361, -2363, and -2365 (Fed. Cir. May 24, 2023) In this week’s Case of the Week,...
/PRNewswire/ -- MicroVention, Inc., a wholly owned subsidiary of Terumo Corporation, announced the successful completion of its first enrollment in a...